stockrowLivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.
- Revenue
- +9.88%
- EPS
- +27.4%
- Free cash flow
- −31.0%
- Total debt
- −31.2%
Quarter to September 2026, against a year earlier
Follow LIVN
Alert me
LivaNova PLC (LIVN) Gross margin
LivaNova PLC's gross margin over the twelve months to 30 September 2026 was 67.8%, up 0.1 percentage points from fiscal 2025 (67.7%). Over the past ten years it has ranged from 58.0% (fiscal 2016) to 90.6% (fiscal 2015); the current reading is higher than 64% of that period. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 67.7% | (0.38) |
| FY2024 | 68.1% | 2.57 |
| FY2023 | 65.5% | (3.69) |
| FY2022 | 69.2% | 1.02 |
| FY2021 | 68.2% | 4.53 |
| FY2020 | 63.7% | (3.10) |
| FY2019 | 66.8% | 0.37 |
| FY2018 | 66.4% | 2.00 |
| FY2017 | 64.4% | 6.40 |
| FY2016 | 58.0% | (32.64) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 67.4% | (2.66) |
| Jun 2026 | 70.1% | 2.78 |
| Mar 2026 | 67.3% | 0.86 |
| Dec 2025 | 66.4% | (2.01) |
| 45 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| AXGN AxoGen, Inc. compare | 74.2% |
| IRTC iRhythm Holdings, Inc. compare | 72.3% |
| TXG 10x Genomics compare | 70.0% |
| LIVN LivaNova PLC | 67.8% |
| HAE Haemonetics Corporation compare | 59.6% |
| BIO Bio-Rad Laboratories, Inc. compare | 51.3% |
| BRKR Bruker Corporation compare | 47.7% |
| NEOG Neogen Corporation compare | 47.4% |
| ITGR Integer Holdings Corporation compare | 24.6% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on LIVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement